Stock report · NASDAQ
Passage Bio, Inc. (PASG)
…
PASG stock chart
Loading chart…
Key statistics
About Passage Bio, Inc.
Passage Bio Inc (PASG) is a clinical-stage genetic medicines company based in the United States. The company focuses on developing transformative therapies for rare, monogenic central nervous system (CNS) diseases. Its proprietary technology platform allows the company to develop viral vector-mediated gene therapies with the potential to restore function to cells damaged by disease. The company was founded in 2017 and is headquartered in Philadelphia, Pennsylvania.
Passage Bio financials at a glance
Quotes may be delayed. Market data is provided for information only and is not investment advice; see our disclaimer.